We firstly revealed that AFR was superior to Alb, Fib, NLR, PLR, and MLR to independently predict OS in patients with LC, especially non‐small cell lung cancer (NSCLC), and it could improve predicted efficacy of the prognostic nomogram for NSCLC. The gene discussed is ALB; the disease is non-small cell lung carcinoma.